“Aptamarker prediction of brain amyloid-{beta} status in cognitively normal individuals at risk for Alzheimer’s disease,” by Gregory Penner, Soizic Lecocq, Anaëlle Chopin, Ximena Vedoya, Simone Lista, Andrea Vergallo, Enrica Cavedo, Francois-Xavier Lejeune, Bruno Dubois, Harald Hampel, the INSIGHT-preAD study group, for the Alzheimer Precision Medicine Initiative (APMI) (PLoS ONE 16(1): e0243902. doi.org/10.1371/journal.pone.0243902, XML, HTML, and .pdf format, 14p.).
journals.plos.org/plosone/article?id=10.1371/journal.pone.0243902
